CD4 and glioblastoma: In another study, dexamethasone treatment before glioblastoma resection affected the main immune cell populations, including CD4+ and CD8+ T cells, CD66b+ neutrophils, CD14+ monocytes, non-Vδ2 γδT cells, and NK cells (especially CD56high) (103).